White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab-Reference-Cited by-同舟云学术

White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

Published:2019-10-16 Issue:3 Volume:145 Page:461-466
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Estephan Fayez,Ye Xiaobu,Dzaye Omar,Wagner-Johnston Nina,Swinnen Lode,Gladstone Douglas E.,Ambinder Rich,Kamson David Olayinka,Lambrecht Sebastian,Grossman Stuart A.,Lin Doris D. M.,Holdhoff Matthias^ORCID

Funder

Sidney Kimmel Comprehensive Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-019-03279-9.pdf

Reference21 articles.

1. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neurooncology 17(Suppl 4):iv1–iv62. https://doi.org/10.1093/neuonc/nov189

2. Holdhoff M, Ambady P, Abdelaziz A, Sarai G, Bonekamp D, Blakeley J, Grossman SA, Ye X (2014) High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology 83:235–239. https://doi.org/10.1212/WNL.0000000000000593

3. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM (2004) Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 62:451–456

4. Salkade PR, Lim TA (2012) Methotrexate-induced acute toxic leukoencephalopathy. J Cancer Res Ther 8:292–296. https://doi.org/10.4103/0973-1482.98993

5. McKinney AM, Kieffer SA, Paylor RT, SantaCruz KS, Kendi A, Lucato L (2009) Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 193:192–206. https://doi.org/10.2214/AJR.08.1176

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation;Bone Marrow Transplantation;2024-08-09

2. Involved-Site Radiation Therapy Enables Effective Disease Control in Parenchymal Low-Grade Primary Cerebral Lymphoma;Cancers;2023-11-24

3. Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens;Neurology;2023-10-24

4. The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series;CNS Oncology;2021-03-01

5. Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial;Neuro-Oncology;2021-02-09